Injectable glycoprotein IIb/IIIa receptor antagonists for reversible platelet inhibition during acute coronary syndromes and percutaneous coronary interventions. Employed in cardiac catheterization laboratories by interventional cardiologists. Procured by hospitals from specialized pharmaceutical distributors for procedural anticoagulation.